Genmab reported DKK1.34B in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 59.83M 1.93M
AstraZeneca AZN:LN 22594M 1055M
Bayer BAYN:GR € 29403M 676M
Galapagos GLPG:NA € 566.47M 9.02M
Genmab GEN:DC DK 1339M 229M
GRIFOLS GRF:SM € 1921.48M 360.62M
Hikma Pharmaceutical HIK:LN 1.02B 56M
Immunogen IMGN:US $ 84.12M 16.83M
Lonza Group LONN:SW 2.37B 739M
Novartis NOVN:VX SF 30208M 328M
William Demant Holding WDH:DC 10.97B 1.5B